MGLL and Alzheimer disease: Moreover, inhibitors targeting fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) have demonstrated efficacy in reversing cognitive impairments and alleviating neuroinflammation in mouse models of AD [82].